Tandem Diabetes Care
Update in progressTNDM (NasdaqGM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Tandem Diabetes Care, Inc. designs, develops, and markets insulin delivery solutions for people with diabetes in the U.S. and worldwide. Its offerings include the t:slim X2 insulin delivery system and the Tandem Mobi automated insulin delivery pump, plus single-use cartridges and infusion sets. It also provides the Tandem Device Updater, Tandem Source data platform, and the Sugarmate mobile app. The company collaborates with the University of Virginia Center for Diabetes Technology on automated closed-loop systems. Formerly Phluid Inc., it renamed in 2008. Founded in 2006 and based in San Diego.
Company score
- Sentiment
- -0.53
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.02
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.77
- Governance
- -0.47
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.34
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.43
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGM (NGM)
- LocationUnited States
- CEOMr. John F. Sheridan
- Founded2006
- Employees2,500
- Websitewww.tandemdiabetes.com
Identifiers
- ISINUS8753722037
- FIGIBBG0019V9M65
- LEI549300JEPFOD0K4D3I05
- CUSIP875372104
- CIK0001438133